Related Experiment Video
Updated: Aug 15, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Action of adrenergic agonists on resistance v capacitance vessels during cardiopulmonary bypass
A Baraka1, S Haroun, M Baroody
1Department of Anesthesiology, American University of Beirut, Lebanon.
Abstract:
The peripheral vascular effects of three different adrenergic agonists were investigated in 13 patients undergoing valve replacement during cardiopulmonary bypass (CPB). The venous reservoir (RV) and mean arterial pressure (MAP) were used as indices of the changes in venous capacitance and arterial resistance, respectively, produced by the adrenergic agonists. Isoproterenol, a pure beta-adrenergic agonist, decreased both MAP and RV. Norepinephrine (NE), which activates both alpha 1- and alpha 2-receptors in humans, increased both MAP and RV, while phenylephrine (PH) a selective alpha 1-adrenergic agonist, increased only MAP with no significant change in RV. It is concluded that in humans during hypothermic CPB, beta-agonists dilate both the resistance and capacitance vessels, selective alpha 1-adrenergic agonists preferentially constrict the resistance vessels, and non-selective alpha 1- and alpha 2-adrenergic agonists constrict both the resistance and capacitance vessels.
Related Concept Videos
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Cardiopulmonary Resuscitation IV: Pharmacological Management

